Akero Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Akero Therapeutics, Inc. has filed 734 SEC EDGAR filings since 18 Dec 2018

SEC filing history

Showing 26-50 of 734 matching filings.

Per page
25
Current page
2
S-8 POS File 333-237220

S-8 POS

Filing date
09 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-232234

S-8 POS

Filing date
09 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POSASR File 333-279338

POSASR

Filing date
09 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Nov 2025
Reporting date
25 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Nov 2025
Reporting date
24 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38944

DEFA 14A

Filing date
24 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Nov 2025
Reporting date
20 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Nov 2025
Reporting date
17 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91047

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91047

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Nov 2025
Reporting date
12 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91047

SCHEDULE 13G filing

Filing date
12 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFM14A File 001-38944

DEFM14A

Filing date
07 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Nov 2025
Reporting date
04 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
PREM14A File 001-38944

PREM14A

Filing date
24 Oct 2025
Reporting date
24 Oct 2025
Next action
Verify source filing
4

4

Filing date
14 Oct 2025
Reporting date
10 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Oct 2025
Reporting date
08 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Oct 2025
Reporting date
07 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Oct 2025
Reporting date
08 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38944

DEFA14A

Filing date
09 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38944

DEFA14A

Filing date
09 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .